文献速递传染病防控与疫情报告免疫规划

GLaMOR项目对欧盟季节性流感相关死亡率的估计

Estimates of mortality associated with seasonal influenza for the European Union from the GLaMOR project.
PubMed 文献 · Vaccine · 2022-01-31

GLaMOR项目采用多重插补法,基于2002-2011年全球31国(含11个欧盟国家)的流感相关呼吸道死亡率数据,外推至欧盟28国。估计欧盟28国平均每个冬季有27,600例(范围16,200-39,000)呼吸道死亡与季节性流感相关,其中88%为65岁及以上人群,该年龄组死亡率约为65岁以下人群的35倍。未发现老年人疫苗接种覆盖率与流感相关死亡率估计值之间存在负相关。

要点

  • 欧盟28国平均每个冬季流感相关呼吸道死亡27,600例(范围16,200-39,000)。
  • 88%的死亡发生在65岁及以上人群,该年龄组死亡率约为65岁以下人群的35倍。
  • 未发现老年人疫苗接种覆盖率与流感相关死亡率估计值之间存在负相关。

核心结论

  • 欧盟流感相关呼吸道死亡率估计与ECDC估计大致一致。
  • 需要更多研究解释欧盟各国死亡率观察到的差异,以及可能解释欧洲老年人流感疫苗接种项目意外缺乏死亡率获益的偏倚。

研究设计与样本

  • 基于2002-2011年(排除2009年大流行)全球31个国家(其中11个欧盟国家)的流感相关呼吸道死亡率估计,采用多重插补法外推至全球193个国家,包括欧盟28国。
  • 从欧盟资助的VENICE项目获取各国65岁以上人群疫苗接种百分比数据;2006/07参考季节提供估计的21个国家中,数据范围为2%至82%。

主要发现

  • 估计欧盟28国平均每个冬季有27,600例(范围16,200-39,000)呼吸道死亡与季节性流感相关。
  • 88%的死亡发生在65岁及以上人群,该年龄组死亡率约为65岁以下人群的35倍。
  • 欧盟各国估计差异很大;例如老年人死亡率从葡萄牙的每10万人21.6(12.5-35.1)到卢森堡的36.5(16.4-62.5),差异近70%。
  • 未发现老年人疫苗接种覆盖率与流感相关死亡率估计值之间存在负相关。

局限性

  • 需要更多研究解释欧盟各国死亡率观察到的差异。
  • 需要更多研究解释欧洲老年人流感疫苗接种项目意外缺乏死亡率获益的可能偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The European Centres for Disease Prevention and Control (ECDC) estimates that seasonal influenzacauses 4-50 million symptomatic infections in the EU/EEA each year and 15,000-70,000 European citizens die of causes associated with influenza. We used modelling methods to estimate influenza-associated mortality for the European Union by age group and country. METHODS: We compiled influenza-associated respiratory mortality estimates for 31 countries around the world (11 countries in the EU) during 2002-2011 (excluding the 2009 pandemic). From these we extrapolated the influenza mortality burden for all 193 countries of the world, including the 28 countries of the EU, using a multiple imputation approach. To study the effect of vaccination programs, we obtained data from the EU-funded VENICE project regarding the percentage of persons over 65 who were vaccinated in each country; the data ranged from 2% to 82% between the 21 countries which provided estimates for the 2006/07 reference season. RESULTS: We estimated that an average of 27,600 (range 16,200-39,000) respiratory deaths were associated with seasonal influenza in the 28 EU countries per winter; 88% were among people 65 years and older, and the rates of mortality in this age group were roughly 35 times higher compared with those < 65 years. Estimates varied considerably across the EU; for example, rates in the elderly ranged from 21.6 (12.5-35.1) per 100,000 in Portugal to 36.5 (16.4-62.5) in Luxembourg, a difference of nearly 70%. We were unable to find a negative correlation between vaccination coverage rates and influenza-associated mortality estimates in the elderly. CONCLUSION: Our EU estimate of influenza-associated respiratory mortality is broadly consistent with the ECDC estimate. More research is needed to explain the observed variation in mortality across the EU, and on possible bias that could explain the unexpected lack of mortality benefits associated with European elderly influenza vaccination programs.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Paget J, Danielle Iuliano A, Taylor RJ, et al. Estimates of mortality associated with seasonal influenza for the European Union from the GLaMOR project. Vaccine. 2022. PMID: 35094868. doi:10.1016/j.vaccine.2021.11.080

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。